Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition

Khor, 2011, Genetics and pathogenesis of inflammatory bowel disease, Nature, 474, 307, 10.1038/nature10209 Kaser, 2010, Inflammatory bowel disease, Annual Review of Immunology, 28, 573, 10.1146/annurev-immunol-030409-101225 Chassaing, 2011, The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases, Gastroenterology, 140, 1720, 10.1053/j.gastro.2011.01.054 Elson, 2005, Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota, Immunological Reviews, 206, 260, 10.1111/j.0105-2896.2005.00291.x Sartor, 2004, Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics, Gastroenterology, 126, 1620, 10.1053/j.gastro.2004.03.024 Landers, 2002, Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens, Gastroenterology, 123, 689, 10.1053/gast.2002.35379 Mow, 2004, Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease, Gastroenterology, 126, 414, 10.1053/j.gastro.2003.11.015 Quinton, 1998, Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role, Gut, 42, 788, 10.1136/gut.42.6.788 Sutton, 2000, Identification of a novel bacterial sequence associated with Crohn's disease, Gastroenterology, 119, 23, 10.1053/gast.2000.8519 Swidsinski, 2005, Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease, Journal of Clinical Microbiology, 43, 3380, 10.1128/JCM.43.7.3380-3389.2005 Barnich, 2007, Adherent-invasive Escherichia coli and Crohn's disease, Current Opinion in Gastroenterology, 23, 16, 10.1097/MOG.0b013e3280105a38 Feller, 2010, Long-term antibiotic treatment for Crohn's disease: systematic review and meta-analysis of placebo-controlled trials, Clinical Infectious Diseases, 50, 473, 10.1086/649923 Rahimi, 2006, A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease, Clinical Therapeutics, 28, 1983, 10.1016/j.clinthera.2006.12.012 Karimi, 2005, (VSL#3) in arthralgia in patients with ulcerative colitis and Crohn's disease: a pilot study, Drugs Today, 41, 453, 10.1358/dot.2005.41.7.917341 Berni Canani, 2005, Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease, Digestive and Liver Disease, 38, 381, 10.1016/j.dld.2005.10.005 Gorard, 1993, Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone, Gut, 34, 1198, 10.1136/gut.34.9.1198 Papadopoulou, 1995, Remission following an elemental diet or prednisolone in Crohn's disease, Acta Paediatrica, 84, 79, 10.1111/j.1651-2227.1995.tb13490.x Okada, 1990, Controlled trial comparing an elemental diet with prednisolone in the treatment of active Crohn's disease, Hepato-Gastroenterology, 37, 72 O’Moráin, 1984, Elemental diet as primary treatment of acute Crohn's disease: a controlled trial, British Medical Journal (Clinical Research Edition), 288, 1859, 10.1136/bmj.288.6434.1859 Bamba, 2003, Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial, European Journal of Gastroenterology and Hepatology, 15, 151, 10.1097/00042737-200302000-00008 Yamamoto, 2005, Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings, Inflammatory Bowel Diseases, 11, 580, 10.1097/01.MIB.0000161307.58327.96 Fischer, 1973, Hyperalimentation as primary therapy for inflammatory bowel disease, American Journal of Surgery, 125, 165, 10.1016/0002-9610(73)90022-6 Fuchigami, 1982, Effects of total parenteral nutrition on colonic lesions in Crohn's disease: radiographic and endoscopic study, Gastroenterologia Japonica, 17, 521, 10.1007/BF02779129 Ostro, 1985, Total parenteral nutrition and complete bowel rest in the management of Crohn's disease, Journal of Parenteral and Enteral Nutrition, 9, 280, 10.1177/0148607185009003280 Greenberg, 1988, Controlled trial of bowel rest and nutritional support in the management of Crohn's disease, Gut, 29, 1309, 10.1136/gut.29.10.1309 Matsuki, 2004, Use of 16 S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces, Applied and Environment Microbiology, 70, 7220, 10.1128/AEM.70.12.7220-7228.2004 Kibe, 2004, Maturation of the murine cecal microbiota as revealed by terminal restriction fragment length polymorphism and 16 S rRNA gene clone libraries, FEMS Microbiology Letters, 235, 139, 10.1111/j.1574-6968.2004.tb09578.x Sakamoto, 2003, Terminal restriction fragment length polymorphism analysis for human fecal microbiota and its application for analysis of complex bifidobacterial communities, Microbiology and Immunology, 47, 133, 10.1111/j.1348-0421.2003.tb02796.x Matsumoto, 2005, Novel phylogenetic assignment database for terminal-restriction fragment length polymorphism analysis of human colonic microbiota, Journal of Microbiological Methods, 61, 305, 10.1016/j.mimet.2004.12.009 Qin, 2010, A human gut microbial gene catalogue established by metagenomic sequencing, Nature, 464, 59, 10.1038/nature08821 Andoh, 2011, Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis, Journal of Gastroenterology, 46, 479, 10.1007/s00535-010-0368-4 Manichanh, 2006, Reduced diversity of fecal microbiota in Crohn's disease revealed by a metagenomic approach, Gut, 55, 205, 10.1136/gut.2005.073817 Sokol, 2006, Specificities of the fecal microbiota in inflammatory bowel disease, Inflammatory Bowel Diseases, 12, 106, 10.1097/01.MIB.0000200323.38139.c6 Takaishi, 2008, Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease, International Journal of Medical Microbiology, 298, 463, 10.1016/j.ijmm.2007.07.016 Sokol, 2008, Fecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn's disease patients, Proceedings of the National Academy of Sciences, 105, 16731, 10.1073/pnas.0804812105 Sokol, 2009, Low counts of Fecalibacterium prausnitzii in colitis microbiota, Inflammatory Bowel Diseases, 15, 1183, 10.1002/ibd.20903 Kang, 2010, Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray, Inflammatory Bowel Diseases, 16, 2034, 10.1002/ibd.21319 Mondot, 2011, Highlighting new phylogenetic specificities of Crohn's disease microbiota, Inflammatory Bowel Diseases, 17, 185, 10.1002/ibd.21436 Martinez-Medina, 2009, Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E coli (AIEC) in Crohn's disease, Inflammatory Bowel Diseases, 15, 872, 10.1002/ibd.20860 Isenmann, 2002, Interaction of fibronectin and aggregation substance promotes adherence of Enterococcus fecalis to human colon, Digestive Diseases and Sciences, 47, 462, 10.1023/A:1013763331708 Marcinkiewicz, 2007, Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria, International Journal of Experimental Pathology, 88, 155, 10.1111/j.1365-2613.2007.00530.x Bengmark, 1995, Gastrointestinal surface protection and mucosa reconditioning, Journal of Parenteral and Entera Nutrition, 19, 410, 10.1177/0148607195019005410 Salminen, 1995, Gut flora in normal and disordered states, Chemotherapy, 41, 5, 10.1159/000239391 Walker, 2011, High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease, BMC Microbiology, 10, 11 Whelan, 2004, Enteral feeding: the effect on fecal output, the fecal microflora and SCFA concentrations, Proceedings of the Nutrition Society, 63, 105, 10.1079/PNS2003317 Kajiura, 2009, Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis, Digestive Diseases and Sciences, 54, 1892, 10.1007/s10620-008-0574-6 Pimentel, 2004, A 14-day elemental diet is highly effective in normalizing the lactulose breath test, Digestive Diseases and Sciences, 49, 73, 10.1023/B:DDAS.0000011605.43979.e1 Andoh, 2009, Fecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis, Alimentary Pharmacology and Therapeutics, 29, 75, 10.1111/j.1365-2036.2008.03860.x Kishi, 2000, Alteration of V beta usage and cytokine production of CD4+ TCR beta beta homodimer T cells by elimination of Bacteroides vulgatus prevents colitis in TCR alpha-chain-deficient mice, Journal of Immunology, 165, 5891, 10.4049/jimmunol.165.10.5891 Lopez-Marti, 2009, Bacteremia caused by an Enterococcus fecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease, Pediatric Infectious Disease Journal, 28, 663, 10.1097/INF.0b013e318197520d Berkelhammer, 2009, Endocarditis in Crohn's disease, Inflammatory Bowel Diseases, 15, 1293, 10.1002/ibd.20822 Jones, 1987, Comparison of total parenteral nutrition and elemental diet in induction of remission of Crohn's disease. Long-term maintenance of remission by personalized food exclusion diets, Digestive Diseases and Sciences, 32, S100, 10.1007/BF01312473 Moran, 1993, Bowel rest and elemental diet in Crohn's disease, Gastroenterology, 104, 1238, 10.1016/0016-5085(93)90318-7 O'Sullivan, 1998, Nutritional therapy in Crohn's disease, Inflammatory Bowel Diseases, 4, 45, 10.1002/ibd.3780040109 Andou, 2009, Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages, Gastroenterology, 136, 564, 10.1053/j.gastro.2008.09.062 Takagi, 2009, Quality of life of patients and medical cost of half elemental diet as maintenance therapy for Crohn's disease: secondary outcomes of a randomised controlled trial, Digestive and Liver Disease, 41, 390, 10.1016/j.dld.2008.09.007